Caxton Associates (New York)’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$418K Buy
+50,213
New +$371K 0.01% 365
2024
Q3
Sell
-22,531
Closed -$119K 516
2024
Q2
$119K Hold
22,531
﹤0.01% 458
2024
Q1
$123K Hold
22,531
0.01% 435
2023
Q4
$165K Sell
22,531
-121,323
-84% -$800K 0.01% 432
2023
Q3
$1.18M Buy
143,854
+125,625
+689% +$1.12M 0.16% 118
2023
Q2
$192K Buy
+18,229
New +$181K 0.03% 421

Other funds holding ADTN

Caxton Associates (New York)'s ADTN Position: Q4 2024 in Review

Caxton Associates (New York) opened a new position in Adtran (ADTN) in Q4 2024: 50,213 shares worth $418K. The stake represents 0.01% of the portfolio and ranks #365 among its holdings. This is a return to the name: Caxton Associates (New York) previously reported a position in ADTN as recently as Q2 2024.

Caxton Associates (New York) first reported a position in ADTN in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.18M in Q3 2023. 159 funds tracked by Wall St. Rank hold ADTN as of Q4 2024.

  • Caxton Associates (New York) held 50,213 shares of Adtran worth $418K as of Q4 2024.
  • Adtran was a new Caxton Associates (New York) position in Q4 2024.
  • Adtran made up 0.01% of Caxton Associates (New York)'s portfolio in Q4 2024, its #365 holding.
  • Caxton Associates (New York) first reported a position in Adtran in Q2 2023 and has held it in 6 quarters since.
  • Caxton Associates (New York)'s Adtran position peaked at $1.18M in Q3 2023.
  • 159 funds tracked by Wall St. Rank held Adtran as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.